These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53. Trimetazidine: the future of cardiac function? Di Napoli P; Taccardi AA Future Cardiol; 2009 Sep; 5(5):421-4. PubMed ID: 19715405 [No Abstract] [Full Text] [Related]
54. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency]. Gronda E; Mafrici A; Ferrari D; Cataldo G; Salvadè P; Pirelli S; Mauri F; Faletra F; Carù B G Ital Cardiol; 1981; 11(6):803-11. PubMed ID: 7319186 [No Abstract] [Full Text] [Related]
56. [Use of vasodilator agents in the treatment of cardiac insufficiency]. Ruano Calvo FJ; Larman Tellechea M; Pajarón López A Med Clin (Barc); 1984 Oct; 83(11):460-8. PubMed ID: 6150138 [No Abstract] [Full Text] [Related]
57. [Treatment of heart failure in children]. Pipitone S; Manetti A G Ital Cardiol; 1995 Nov; 25(11):1485-90. PubMed ID: 8682250 [No Abstract] [Full Text] [Related]
58. Clinical issues in the management of heart failure. Boccanelli A; Scardovi AB G Ital Cardiol; 1999 Oct; 29(10):1195-8. PubMed ID: 10546133 [No Abstract] [Full Text] [Related]
59. Therapeutic strategies in congestive heart failure and the new inotrope-vasodilator agents. Simonton CA West J Med; 1985 Feb; 142(2):235-44. PubMed ID: 4013252 [No Abstract] [Full Text] [Related]